Cargando…

Successful management of in-transit cutaneous squamous cell carcinoma with anti-PD-1 immunotherapy

This report describes the case of a 70-year-old man with metastatic squamous cell carcinoma (SCC) of the right lower leg. Soon after definitive surgical management of the primary and nodal metastases with curative intent, he relapsed, developing aggressive in-transit metastatic disease and recurrent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furkert, Chris, Martin, Richard, Sharma, Avinash, Rivalland, Gareth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503120/ https://www.ncbi.nlm.nih.gov/pubmed/37715254 http://dx.doi.org/10.1186/s12957-023-03179-3

Ejemplares similares

Cutaneous squamous-cell carcinoma of the head-neck area refractory to chemo-radiotherapy: benefit from anti-PD-1 immunotherapy
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy
por: Ishitsuka, Yosuke, et al.
Publicado: (2021)

Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma
por: Boutros, Andrea, et al.
Publicado: (2021)

The success of anti-PD-1 with chemotherapy for esophageal squamous cell carcinoma
por: van Laarhoven, Hanneke W.M., et al.
Publicado: (2023)

Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma
por: Aboul-Fettouh, Nader, et al.
Publicado: (2021)

Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives
por: Alberti, Andrea, et al.
Publicado: (2022)

Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma
por: Clingan, Philip, et al.
Publicado: (2023)

Case report: The power of immunotherapy in advanced cutaneous squamous cell carcinoma
por: Brockwell, Maximilian, et al.
Publicado: (2023)

Advanced Cutaneous Squamous Cell Carcinoma Management in Immunotherapy Era: Achievements and New Challenges
por: Lorini, Luigi, et al.
Publicado: (2023)

Overcoming Resistance to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma
por: García-Sancha, Natalia, et al.
Publicado: (2021)

Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma
por: Marin-Acevedo, Julian A., et al.
Publicado: (2023)

Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma
por: Khorasanchi, Adam, et al.
Publicado: (2022)

Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma
por: McLean, Luke S., et al.
Publicado: (2022)

Advances in the management of cutaneous squamous cell carcinoma
por: Parikh, Sonal A., et al.
Publicado: (2014)

Update on the Management of Cutaneous Squamous Cell Carcinoma
por: MAUBEC, Eve
Publicado: (2020)

Advances in Cutaneous Squamous Cell Carcinoma Management
por: Burns, Carrick, et al.
Publicado: (2022)

Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
por: Falchook, Gerald S., et al.
Publicado: (2016)

Sex as a Predictor of Response to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma
por: Yeo, Nicholas, et al.
Publicado: (2023)

Nascent verrucous hyperplasia – A transition to cutaneous squamous cell carcinoma
por: Shetty, Sameep S., et al.
Publicado: (2019)

Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report
por: Alloghbi, Abdurahman, et al.
Publicado: (2021)

Anti-PD-1 for the treatment of advanced cutaneous squamous cell carcinoma in elderly patients: a French multicenter retrospective survey
por: Samaran, Quentin, et al.
Publicado: (2022)

Response to anti-PD1 immunotherapy in patients with metastatic cutaneous sarcoma: case reports and literature review
por: Vieira, Aline Cristini, et al.
Publicado: (2020)

Successful treatment of cutaneous squamous cell carcinoma with intralesional cryosurgery: Case report
por: Lee, Chaw-Ning, et al.
Publicado: (2016)

Cutaneous squamous cell carcinoma of the lip successfully treated with rhenium-188 brachytherapy
por: Sabbadini, Chiara, et al.
Publicado: (2023)

In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma
por: Babačić, Haris, et al.
Publicado: (2020)

In-Transit Metastasis of Cutaneous Squamous Cell Carcinoma With Lymphovascular Invasion in an Immunocompetent Patient
por: Stewart, Jacob R, et al.
Publicado: (2022)

Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
por: Fu, Yuyin, et al.
Publicado: (2021)

PD-1 Inhibitors in Elderly and Immunocompromised Patients with Advanced or Metastatic Cutaneous Squamous Cell Carcinoma
por: Yakobson, Alexander, et al.
Publicado: (2023)

Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
por: Sadozai, Hassan, et al.
Publicado: (2017)

A Hybrid Epithelial to Mesenchymal Transition in Ex Vivo Cutaneous Squamous Cell Carcinoma Tissues
por: Pulford, Christopher S., et al.
Publicado: (2022)

Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management
por: Shen, John, et al.
Publicado: (2018)

Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy
por: Herbreteau, Guillaume, et al.
Publicado: (2018)

Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?
por: Zhang, Yaxiong, et al.
Publicado: (2018)

Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinion
por: Argenziano, Giuseppe, et al.
Publicado: (2022)

Multidisciplinary management of giant cervicothoracic cutaneous squamous cell carcinoma
por: López, P.A., et al.
Publicado: (2019)

Update on Management Recommendations for Advanced Cutaneous Squamous Cell Carcinoma
por: García-Foncillas, Jesús, et al.
Publicado: (2022)

Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab
por: Nahar, Kazi J, et al.
Publicado: (2020)

CD8/PD-L1 immunohistochemical reactivity and gene alterations in cutaneous squamous cell carcinoma
por: Nishida, Haruto, et al.
Publicado: (2023)

YAP drives cutaneous squamous cell carcinoma formation and progression
por: Vincent-Mistiaen, Zoé, et al.
Publicado: (2018)

Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: The Current and Future Role of Radiation Therapy in the Era of Immunotherapy
por: Ferini, Gianluca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c4oati76nb6hgalaqegduk9sok